Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy

Condition:   Head & Neck Cancer
Intervention:   Drug: nanoliposomal irinotecan
Sponsors:   National Health Research Institutes, Taiwan;   China Medical University Hospital;   Tri-Service General Hospital;   Taipei Veterans General Hospital, Taiwan;   National Cheng-Kung University Hospital
Not yet recruiting

https://ift.tt/2CsErmC